Pain control and subconjunctival haemorrhage after intravitreal injection using cooled anaesthetic eyedrops and antiseptics: A prospective, double-blind, randomized controlled trial.
Ran MoshkovskyNili GolanEinat Aviel GadotAsaf BarAchiron AsafNaomi FischerOriel SpiererPublished in: Acta ophthalmologica (2023)
The benefit of using cooled anaesthetic eyedrops and antiseptics to alleviate pain and minimise subconjunctival haemorrhage following intravitreal injection was not proven in the general population. It may be beneficial in part for some patients, such as those who regularly use eyedrops, patients with hypertension or those not on antithrombotic therapy.
Keyphrases
- randomized controlled trial
- chronic pain
- end stage renal disease
- vascular endothelial growth factor
- study protocol
- ejection fraction
- neuropathic pain
- diabetic retinopathy
- blood pressure
- chronic kidney disease
- newly diagnosed
- double blind
- clinical trial
- peritoneal dialysis
- ultrasound guided
- prognostic factors
- age related macular degeneration
- systematic review
- spinal cord injury
- spinal cord
- stem cells
- placebo controlled
- mesenchymal stem cells
- bone marrow
- endothelial cells
- phase ii
- meta analyses